Healthcare provider profile · identity verified

Manish Dimri, MD

Internal Medicine · ODESSA, TX · NPI 1609823111

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	563	155
Rosuvastatin Calcium	Rosuvastatin Calcium	398	127
Atorvastatin Calcium	Atorvastatin Calcium	305	94
Amlodipine Besylate	Amlodipine Besylate	297	93
Pantoprazole Sodium	Pantoprazole Sodium	276	92
Tamsulosin Hcl	Tamsulosin Hcl	272	91
Losartan Potassium	Losartan Potassium	251	76
Omeprazole	Omeprazole	242	72
Lisinopril	Lisinopril	209	67
Gabapentin	Gabapentin	200	70
Ozempic	Semaglutide	194	38
Metformin Hcl Er	Metformin Hcl	189	60
Meloxicam	Meloxicam	188	64
Escitalopram Oxalate	Escitalopram Oxalate	174	58
Glimepiride	Glimepiride	171	53
Metoprolol Succinate	Metoprolol Succinate	168	52
Azithromycin	Azithromycin	160	128
Tramadol Hcl	Tramadol Hcl	158	48
Simvastatin	Simvastatin	149	42
Zolpidem Tartrate	Zolpidem Tartrate	143	34
Hydrochlorothiazide	Hydrochlorothiazide	132	46
Albuterol Sulfate Hfa	Albuterol Sulfate	131	57
Alprazolam	Alprazolam	131	36
Pioglitazone Hcl	Pioglitazone Hcl	129	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	28
Montelukast Sodium	Montelukast Sodium	128	42
Furosemide	Furosemide	125	45
Allopurinol	Allopurinol	123	35
Methylprednisolone	Methylprednisolone	122	99
Carvedilol	Carvedilol	109	32
Jardiance	Empagliflozin	108	31
Bupropion Xl	Bupropion Hcl	104	33
Eliquis	Apixaban	104	32
Clopidogrel	Clopidogrel Bisulfate	102	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	102	33
Atenolol	Atenolol	98	35
Donepezil Hcl	Donepezil Hcl	98	25
Potassium Chloride	Potassium Chloride	96	37
Metformin Hcl	Metformin Hcl	95	31
Fenofibrate	Fenofibrate Nanocrystallized	92	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	88	31
Pravastatin Sodium	Pravastatin Sodium	88	23
Sertraline Hcl	Sertraline Hcl	88	22
Trazodone Hcl	Trazodone Hcl	88	25
Clonazepam	Clonazepam	87	18
Ezetimibe	Ezetimibe	82	30
Temazepam	Temazepam	81	18
Metoprolol Tartrate	Metoprolol Tartrate	77	24
Synthroid	Levothyroxine Sodium	71	21
Mounjaro	Tirzepatide	66	16
Oxybutynin Chloride	Oxybutynin Chloride	62	25
Alendronate Sodium	Alendronate Sodium	60	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	45
Lorazepam	Lorazepam	58	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	23
Citalopram Hbr	Citalopram Hydrobromide	57	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	22
Memantine Hcl	Memantine Hcl	55	suppressed
Celecoxib	Celecoxib	54	25
Januvia	Sitagliptin Phosphate	50	13
Quetiapine Fumarate	Quetiapine Fumarate	50	15
Olmesartan Medoxomil	Olmesartan Medoxomil	48	17
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	47	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	46	16
Azelastine Hcl	Azelastine Hcl	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	13
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	45	15
Spironolactone	Spironolactone	45	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	13
Duloxetine Hcl	Duloxetine Hcl	44	14
Diclofenac Sodium	Diclofenac Sodium	43	17
Levofloxacin	Levofloxacin	43	37
Mirtazapine	Mirtazapine	42	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	35
Hydralazine Hcl	Hydralazine Hcl	41	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	30
Finasteride	Finasteride	40	13
Fluticasone Propionate	Fluticasone Propionate	40	15
Estradiol	Estradiol	37	20
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	37	14
Ondansetron Odt	Ondansetron	37	25
Ropinirole Hcl	Ropinirole Hcl	36	11
Farxiga	Dapagliflozin Propanediol	35	suppressed
Fenofibrate	Fenofibrate	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	29
Venlafaxine Hcl Er	Venlafaxine Hcl	33	11
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Prednisone	Prednisone	31	18
Testosterone Cypionate	Testosterone Cypionate	31	12
Clonidine Hcl	Clonidine Hcl	30	13
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Telmisartan	Telmisartan	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	13
Doxycycline Hyclate	Doxycycline Hyclate	28	17
Olanzapine	Olanzapine	28	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	28	23
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Glipizide	Glipizide	27	suppressed
Fluconazole	Fluconazole	26	15
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Methocarbamol	Methocarbamol	26	suppressed
Methotrexate	Methotrexate Sodium	26	suppressed
Terbinafine Hcl	Terbinafine Hcl	26	16
Tizanidine Hcl	Tizanidine Hcl	26	15
Pregabalin	Pregabalin	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	12
Glipizide Er	Glipizide	23	suppressed
Megestrol Acetate	Megestrol Acetate	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Famotidine	Famotidine	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Euthyrox	Levothyroxine Sodium	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	19	suppressed
Ramipril	Ramipril	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Buspirone Hcl	Buspirone Hcl	18	suppressed
Np Thyroid	Thyroid,pork	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Cephalexin	Cephalexin	16	15
Colchicine	Colchicine	16	suppressed
Hydrocortisone	Hydrocortisone	16	11
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	15	suppressed
Amoxicillin	Amoxicillin	15	13
Valsartan	Valsartan	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Glyburide	Glyburide	14	suppressed
Imipramine Hcl	Imipramine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Primidone	Primidone	14	suppressed
Toprol Xl	Metoprolol Succinate	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Enbrel	Etanercept	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Letrozole	Letrozole	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Lyrica	Pregabalin	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error